Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin

Michael Lauseker, Katharina Bachl, Anna Turkina, Edgar Faber, Witold Prejzner, Ulla Olsson-Stromberg, Michele Baccarani, Elza Lomaia, Daniela Zackova, Gert Ossenkoppele, Laimonas Griskevicius, Gabriele Schubert-Fritschle, Tomasz Sacha, Sonja Heibl, Perttu Koskenvesa, Andrija Bogdanovic, Richard E. Clark, Joelle Guilhot, Verena S. Hoffmann, Joerg HasfordAndreas Hochhaus, Markus Pfirrmann

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Alkuperäiskielienglanti
LehtiAmerican Journal of Hematology
Vuosikerta94
Numero11
Sivut1236-1243
Sivumäärä8
ISSN0361-8609
DOI - pysyväislinkit
TilaJulkaistu - marraskuuta 2019
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

  • 3122 Syöpätaudit

Lainaa tätä

Lauseker, Michael ; Bachl, Katharina ; Turkina, Anna ; Faber, Edgar ; Prejzner, Witold ; Olsson-Stromberg, Ulla ; Baccarani, Michele ; Lomaia, Elza ; Zackova, Daniela ; Ossenkoppele, Gert ; Griskevicius, Laimonas ; Schubert-Fritschle, Gabriele ; Sacha, Tomasz ; Heibl, Sonja ; Koskenvesa, Perttu ; Bogdanovic, Andrija ; Clark, Richard E. ; Guilhot, Joelle ; Hoffmann, Verena S. ; Hasford, Joerg ; Hochhaus, Andreas ; Pfirrmann, Markus. / Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin. Julkaisussa: American Journal of Hematology. 2019 ; Vuosikerta 94, Nro 11. Sivut 1236-1243.
@article{4d95f5e909c74ef79b6f2901d5055a68,
title = "Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin",
keywords = "WORLD-HEALTH-ORGANIZATION, CHRONIC MYELOGENOUS LEUKEMIA, TYROSINE KINASE INHIBITORS, 2904 CML PATIENTS, RANDOMIZED CML, SURVIVAL, MANAGEMENT, IMATINIB, ERA, RECOMMENDATIONS, 3122 Cancers",
author = "Michael Lauseker and Katharina Bachl and Anna Turkina and Edgar Faber and Witold Prejzner and Ulla Olsson-Stromberg and Michele Baccarani and Elza Lomaia and Daniela Zackova and Gert Ossenkoppele and Laimonas Griskevicius and Gabriele Schubert-Fritschle and Tomasz Sacha and Sonja Heibl and Perttu Koskenvesa and Andrija Bogdanovic and Clark, {Richard E.} and Joelle Guilhot and Hoffmann, {Verena S.} and Joerg Hasford and Andreas Hochhaus and Markus Pfirrmann",
year = "2019",
month = "11",
doi = "10.1002/ajh.25628",
language = "English",
volume = "94",
pages = "1236--1243",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley",
number = "11",

}

Lauseker, M, Bachl, K, Turkina, A, Faber, E, Prejzner, W, Olsson-Stromberg, U, Baccarani, M, Lomaia, E, Zackova, D, Ossenkoppele, G, Griskevicius, L, Schubert-Fritschle, G, Sacha, T, Heibl, S, Koskenvesa, P, Bogdanovic, A, Clark, RE, Guilhot, J, Hoffmann, VS, Hasford, J, Hochhaus, A & Pfirrmann, M 2019, 'Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin', American Journal of Hematology, Vuosikerta 94, Nro 11, Sivut 1236-1243. https://doi.org/10.1002/ajh.25628

Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin. / Lauseker, Michael; Bachl, Katharina; Turkina, Anna; Faber, Edgar; Prejzner, Witold; Olsson-Stromberg, Ulla; Baccarani, Michele; Lomaia, Elza; Zackova, Daniela; Ossenkoppele, Gert; Griskevicius, Laimonas; Schubert-Fritschle, Gabriele; Sacha, Tomasz; Heibl, Sonja; Koskenvesa, Perttu; Bogdanovic, Andrija; Clark, Richard E.; Guilhot, Joelle; Hoffmann, Verena S.; Hasford, Joerg; Hochhaus, Andreas; Pfirrmann, Markus.

julkaisussa: American Journal of Hematology, Vuosikerta 94, Nro 11, 11.2019, s. 1236-1243.

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

TY - JOUR

T1 - Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin

AU - Lauseker, Michael

AU - Bachl, Katharina

AU - Turkina, Anna

AU - Faber, Edgar

AU - Prejzner, Witold

AU - Olsson-Stromberg, Ulla

AU - Baccarani, Michele

AU - Lomaia, Elza

AU - Zackova, Daniela

AU - Ossenkoppele, Gert

AU - Griskevicius, Laimonas

AU - Schubert-Fritschle, Gabriele

AU - Sacha, Tomasz

AU - Heibl, Sonja

AU - Koskenvesa, Perttu

AU - Bogdanovic, Andrija

AU - Clark, Richard E.

AU - Guilhot, Joelle

AU - Hoffmann, Verena S.

AU - Hasford, Joerg

AU - Hochhaus, Andreas

AU - Pfirrmann, Markus

PY - 2019/11

Y1 - 2019/11

KW - WORLD-HEALTH-ORGANIZATION

KW - CHRONIC MYELOGENOUS LEUKEMIA

KW - TYROSINE KINASE INHIBITORS

KW - 2904 CML PATIENTS

KW - RANDOMIZED CML

KW - SURVIVAL

KW - MANAGEMENT

KW - IMATINIB

KW - ERA

KW - RECOMMENDATIONS

KW - 3122 Cancers

U2 - 10.1002/ajh.25628

DO - 10.1002/ajh.25628

M3 - Article

VL - 94

SP - 1236

EP - 1243

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 11

ER -